RockBio Venture ApS: Financial statements 2025
CVR: 44444364
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
RockBio Venture ApS (CVR 44444364) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,614 and a net result of DKK -7,569. Equity in the 2025 report amounted to DKK 78,122. The solvency ratio was 90.8%.
- Revenue
- DKK 0
- Gross Profit
- DKK -5,614
- Profit/Loss
- DKK -7,569
- Equity
- DKK 78,122
- Total Assets
- DKK 86,065
Official annual report
How creditworthy is RockBio Venture ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
RockBio Venture ApS has published its interim report for the period November 20, 2023 to December 31, 2024.
About RockBio Venture ApS
RockBio Venture ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jaeyong Choi and Pierre Marie Christian Theurey. The company is owned by XAU Holdings ApS and Theurey BioPharma ApS. In 2025, the company reported a gross profit of DKK -5,614 and a net result of DKK -7,569. Equity in the 2025 report amounted to DKK 78,122.